fluorodeoxyglucose f18 has been researched along with Tuberculosis, Splenic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huo, L; Jin, X; Li, F; Liu, Y; Wang, T | 1 |
| Basu, S; Chhajed, PN; Shejul, Y | 1 |
2 other study(ies) available for fluorodeoxyglucose f18 and Tuberculosis, Splenic
| Article | Year |
|---|---|
Hepatosplenic Tuberculosis on Pretherapy and Posttherapy FDG PET/CT.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Tuberculosis, Hepatic; Tuberculosis, Splenic | 2020 |
18F-FDG PET and PET/CT in diagnosis and treatment monitoring of pyrexia of unknown origin due to tuberculosis with prominent hepatosplenic involvement.
Topics: Adult; Antitubercular Agents; Diagnosis, Differential; Female; Fever; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Liver; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Spleen; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis; Tuberculosis, Hepatic; Tuberculosis, Splenic; Whole Body Imaging | 2014 |